💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Quest Diagnostics aims to stoke shareholder value via higher growth and operational enhancements

Published 11/11/2016, 08:06 AM
Quest Diagnostics aims to stoke shareholder value via higher growth and operational enhancements
DGX
-
  • At is Investor Day today, Quest Diagnostics (NYSE:DGX) will present its two-point plan to build shareholder value via ramping up growth and driving operational improvements. It expects to increase its annual top line growth to 3 - 5% for the period 2017 - 2020 with mid-to-high single digit earnings growth. A 12.5% dividend raise ($1.80 annually) underscores management's bullishness.
  • The company intends to accelerate annual revenue growth 1 - 2% organically and via strategic acquisitions. Other key initiatives include partnering with health plans and hospital systems to increase Quest's addressable market, expanding advanced diagnostics through R&D, increasing its retail presence, driven mainly by its presence in Safeway stores and the initiation of direct access testing in two states, and building a business in population health supported by data analytics and extended care services.
  • It operational initiatives include driving $1.1B in cost savings this year and $1.3B by the end of next year, reduce denials by payers, reduce bad debt expense and standardize/optimize laboratory and operational processes including digitizing processes related to the customer experience (i.e., appointment scheduling, check-in registration, test results reporting).
  • The company also intends to complete six asset sales which are expected to generate gross proceeds of more than $1B as it refocuses on diagnostic information services.
  • 2016 Guidance: Revenues: ~$7.51B; non-GAAP EPS: $5.07 - 5.12.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.